María Angeles Solinís Aspiazu (María Ángeles Solinís, María Ángeles Solinís Aspiazu)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 27

Top Topics

Urinary Tract Infection

Systematic Review

Top Venues

BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy

Antibiotics (Basel, Switzerland)

Drug delivery and translational research

This page only lists publications with an associated author ORCID identifier.

Publications

Marina Beraza-Millor, Julen Rodríguez-Castejón, Ana Del Pozo-Rodríguez, Alicia Rodríguez-Gascón, María Angeles Solinís Aspiazu
Systematic Review of Genetic Substrate Reduction Therapy in Lysosomal Storage Diseases: Opportunities, Challenges and Delivery Systems. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (5) (2024)
Julen Rodríguez-Castejón, Marina Beraza-Millor, María Angeles Solinís Aspiazu, Alicia Rodríguez-Gascón, Ana Del Pozo-Rodríguez
Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review. Drug delivery and translational research (2024)
Helena Barrasa, Miguel Angel Morán, Leire Fernández-Ciriza, Arantxazu Isla, María Angeles Solinís Aspiazu, Andrés Canut-Blasco, Alicia Rodríguez-Gascón
Optimizing Antibiotic Therapy for Stenotrophomonas maltophilia Infections in Critically Ill Patients: A Pharmacokinetic/Pharmacodynamic Approach. Antibiotics (Basel, Switzerland) 13 (6) (2024)
Helena Barrasa, Miguel Angel Morán, Leire Fernández-Ciriza, Arantxazu Isla, María Angeles Solinís Aspiazu, Andrés Canut-Blasco, Alicia Rodríguez-Gascón
Optimizing Antibiotic Therapy for Stenotrophomonas maltophilia Infections in Critically Ill Patients: A Pharmacokinetic/Pharmacodynamic Approach. Antibiotics (Basel, Switzerland) 13 (6) (2024)
Marina Beraza-Millor, Julen Rodríguez-Castejón, Ana Del Pozo-Rodríguez, Alicia Rodríguez-Gascón, María Angeles Solinís Aspiazu
Systematic Review of Genetic Substrate Reduction Therapy in Lysosomal Storage Diseases: Opportunities, Challenges and Delivery Systems. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (5) (2024)
Xabier Aizpurua-Arruti, Shalom Charlie I Benrimoj, Estibaliz Goyenechea, Arantxazu Isla, Ainhoa Oñatibia-Astibia, Amaia Malet-Larrea, Miguel Angel Gastelurrutia, Olatz Cuevas, Julen Rodríguez-Castejón, Saioa Domingo-Echaburu, María Angeles Solinís Aspiazu, Montserrat Garcia, Ana Del Pozo-Rodríguez
Outcomes of Community Pharmacy Interventions on Patients with Medicines Under Additional Monitoring. Integrated pharmacy research & practice 13 (2024)
Marina Beraza-Millor, Julen Rodríguez-Castejón, Ana Del Pozo-Rodríguez, Alicia Rodríguez-Gascón, María Angeles Solinís Aspiazu
Systematic Review of Genetic Substrate Reduction Therapy in Lysosomal Storage Diseases: Opportunities, Challenges and Delivery Systems. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 38 (5) (2024)
Marina Beraza-Millor, Julen Rodríguez-Castejón, Ana Del Pozo-Rodríguez, Alicia Rodríguez-Gascón, María Angeles Solinís Aspiazu
Systematic Review of Genetic Substrate Reduction Therapy in Lysosomal Storage Diseases: Opportunities, Challenges and Delivery Systems. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2024)
Xabier Aizpurua-Arruti, Shalom Charlie I Benrimoj, Estibaliz Goyenechea, Arantxazu Isla, Ainhoa Oñatibia-Astibia, Amaia Malet-Larrea, Miguel Angel Gastelurrutia, Olatz Cuevas, Julen Rodríguez-Castejón, Saioa Domingo-Echaburu, María Angeles Solinís Aspiazu, Montserrat Garcia, Ana Del Pozo-Rodríguez
Outcomes of Community Pharmacy Interventions on Patients with Medicines Under Additional Monitoring. Integrated pharmacy research & practice 13 (2024)
Julen Rodríguez-Castejón, Marina Beraza-Millor, María Angeles Solinís Aspiazu, Alicia Rodríguez-Gascón, Ana Del Pozo-Rodríguez
Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review. Drug delivery and translational research (2024)
Alicia Rodríguez-Gascón, Ana Alarcia-Lacalle, María Angeles Solinís Aspiazu, Ana Del Pozo-Rodríguez, Zuriñe Abajo, María Cabero, Andrés Canut-Blasco, Arantxazu Isla
Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections? Pharmaceutics 15 (4) (2023)
Alicia Rodríguez-Gascón, Ana Alarcia-Lacalle, María Angeles Solinís Aspiazu, Ana Del Pozo-Rodríguez, Zuriñe Abajo, María Cabero, Andrés Canut-Blasco, Arantxazu Isla
Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections? Pharmaceutics 15 (4) (2023)
Marina Beraza-Millor, Julen Rodríguez-Castejón, Jonatan Miranda, Ana Del Pozo-Rodríguez, Alicia Rodríguez-Gascón, María Angeles Solinís Aspiazu
Novel Golden Lipid Nanoparticles with Small Interference Ribonucleic Acid for Substrate Reduction Therapy in Fabry Disease. Pharmaceutics 15 (7) (2023)
Alicia Rodríguez-Gascón, Ana Alarcia-Lacalle, María Angeles Solinís Aspiazu, Ana Del Pozo-Rodríguez, Zuriñe Abajo, María Cabero, Andrés Canut-Blasco, Arantxazu Isla
Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections? Pharmaceutics 15 (4) (2023)
Alicia Rodríguez-Gascón, Ana Alarcia-Lacalle, María Angeles Solinís Aspiazu, Ana Del Pozo-Rodríguez, Zuriñe Abajo, María Cabero, Andrés Canut-Blasco, Arantxazu Isla
Pharmacokinetic/Pharmacodynamic Analysis of Oral Calcium Fosfomycin: Are Urine Levels Sufficient to Ensure Efficacy for Urinary Tract Infections? Pharmaceutics 15 (4) (2023)
Julen Rodríguez-Castejón, Itziar Gómez-Aguado, Marina Beraza-Millor, María Angeles Solinís Aspiazu, Ana Del Pozo-Rodríguez, Alicia Rodríguez-Gascón
Galactomannan-Decorated Lipidic Nanocarrier for Gene Supplementation Therapy in Fabry Disease. Nanomaterials (Basel, Switzerland) 12 (14) (2022)
Alicia Rodríguez-Gascón, María Angeles Solinís Aspiazu, Arantxazu Isla
The Role of PK/PD Analysis in the Development and Evaluation of Antimicrobials. Pharmaceutics 13 (6) (2021)
Julen Rodríguez-Castejón, Ana Alarcia-Lacalle, Itziar Gómez-Aguado, Mónica Vicente-Pascual, María Angeles Solinís Aspiazu, Ana Del Pozo-Rodríguez, Alicia Rodríguez-Gascón
α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice. Pharmaceutics 13 (6) (2021)
Alicia Rodríguez-Gascón, Amaia Aguirre-Quiñonero, María Angeles Solinís Aspiazu, Andrés Canut-Blasco
Pharmacokinetic/Pharmacodynamic Analysis of Tedizolid Phosphate Compared to Linezolid for the Treatment of Infections Caused by Gram-Positive Bacteria. Antibiotics (Basel, Switzerland) 10 (7) (2021)
Ana Valero, Alicia Rodríguez-Gascón, Arantxazu Isla, Helena Barrasa, Ester Del Barrio-Tofiño, Antonio Oliver, Andrés Canut-Blasco, María Angeles Solinís Aspiazu
Pseudomonas aeruginosa Susceptibility in Spain: Antimicrobial Activity and Resistance Suppression Evaluation by PK/PD Analysis. Pharmaceutics 13 (11) (2021)
Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Marina Beraza-Millor, Mónica Vicente-Pascual, Alicia Rodríguez-Gascón, Sara Garelli, Luigi Battaglia, Ana Del Pozo-Rodríguez, María Angeles Solinís Aspiazu
mRNA-Based Nanomedicinal Products to Address Corneal Inflammation by Interleukin-10 Supplementation. Pharmaceutics 13 (9) (2021)
Idoia Bilbao-Meseguer, Helena Barrasa, Eduardo Asin-Prieto, Ana Alarcia-Lacalle, Alicia Rodríguez-Gascón, Javier Maynar, José Ángel Sánchez-Izquierdo, Goiatz Balziskueta, María Sánchez-Bayton Griffith, Nerea Quilez Trasobares, María Angeles Solinís Aspiazu, Arantxazu Isla
Population Pharmacokinetics of Levetiracetam and Dosing Evaluation in Critically Ill Patients with Normal or Augmented Renal Function. Pharmaceutics 13 (10) (2021)
Ana Alarcia-Lacalle, Helena Barrasa, Javier Maynar, Andrés Canut-Blasco, Carmen Gómez-González, María Angeles Solinís Aspiazu, Arantxazu Isla, Alicia Rodríguez-Gascón
Quantification of Ceftaroline in Human Plasma Using High-Performance Liquid Chromatography with Ultraviolet Detection: Application to Pharmacokinetic Studies. Pharmaceutics 13 (7) (2021)
Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Mónica Vicente-Pascual, Alicia Rodríguez-Gascón, María Angeles Solinís Aspiazu, Ana Del Pozo-Rodríguez
Nanomedicines to Deliver mRNA: State of the Art and Future Perspectives. Nanomaterials (Basel, Switzerland) 10 (2) (2020)
Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Mónica Vicente-Pascual, Alicia Rodríguez-Gascón, Ana Del Pozo-Rodríguez, María Angeles Solinís Aspiazu
Nucleic Acid Delivery by Solid Lipid Nanoparticles Containing Switchable Lipids: Plasmid DNA vs. Messenger RNA. Molecules (Basel, Switzerland) 25 (24) (2020)
Mónica Vicente-Pascual, Itziar Gómez-Aguado, Julen Rodríguez-Castejón, Alicia Rodríguez-Gascón, Elisabetta Muntoni, Luigi Battaglia, Ana Del Pozo-Rodríguez, María Angeles Solinís Aspiazu
Topical Administration of SLN-Based Gene Therapy for the Treatment of Corneal Inflammation by De Novo IL-10 Production. Pharmaceutics 12 (6) (2020)
Idoia Bilbao-Meseguer, Alicia Rodríguez-Gascón, Helena Barrasa, Arantxazu Isla, María Angeles Solinís Aspiazu
Augmented Renal Clearance in Critically Ill Patients: A Systematic Review. Clinical pharmacokinetics 57 (9) (2019)